GB201212816D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201212816D0
GB201212816D0 GBGB1212816.1A GB201212816A GB201212816D0 GB 201212816 D0 GB201212816 D0 GB 201212816D0 GB 201212816 A GB201212816 A GB 201212816A GB 201212816 D0 GB201212816 D0 GB 201212816D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1212816.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to GBGB1212816.1A priority Critical patent/GB201212816D0/en
Publication of GB201212816D0 publication Critical patent/GB201212816D0/en
Priority to GB1312819.4A priority patent/GB2504615A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
GBGB1212816.1A 2012-07-19 2012-07-19 Novel compounds Ceased GB201212816D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1212816.1A GB201212816D0 (en) 2012-07-19 2012-07-19 Novel compounds
GB1312819.4A GB2504615A (en) 2012-07-19 2013-07-18 Fused aminodihydrothiazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1212816.1A GB201212816D0 (en) 2012-07-19 2012-07-19 Novel compounds

Publications (1)

Publication Number Publication Date
GB201212816D0 true GB201212816D0 (en) 2012-09-05

Family

ID=46881623

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1212816.1A Ceased GB201212816D0 (en) 2012-07-19 2012-07-19 Novel compounds
GB1312819.4A Withdrawn GB2504615A (en) 2012-07-19 2013-07-18 Fused aminodihydrothiazine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1312819.4A Withdrawn GB2504615A (en) 2012-07-19 2013-07-18 Fused aminodihydrothiazine derivatives

Country Status (1)

Country Link
GB (2) GB201212816D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR103680A1 (en) * 2015-02-23 2017-05-24 Lilly Co Eli BACE1 SELECTIVE INHIBITORS
CN113439121A (en) * 2019-02-13 2021-09-24 普罗拜奥根股份公司 Transposases with enhanced insertion site selection properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201100181D0 (en) * 2011-01-06 2011-02-23 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101140D0 (en) * 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
SG10201601516QA (en) * 2011-01-21 2016-03-30 Eisai R&D Man Co Ltd Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
GB201101139D0 (en) * 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives

Also Published As

Publication number Publication date
GB201312819D0 (en) 2013-12-11
GB2504615A (en) 2014-02-05

Similar Documents

Publication Publication Date Title
HK1201819A1 (en) Novel compounds
GB201207406D0 (en) Novel compounds
HK1212985A1 (en) Novel compounds
EP2922550A4 (en) Novel compounds
HK1208826A1 (en) Novel compounds
GB201212871D0 (en) Novel compounds
EP2922547A4 (en) Novel compounds
IL280595A (en) Novel compounds
GB201209986D0 (en) Novel compounds
GB201222711D0 (en) Novel compounds
GB201207392D0 (en) Novel compounds
GB201209670D0 (en) Novel compounds
GB201212816D0 (en) Novel compounds
GB201222430D0 (en) Novel compounds
GB201222419D0 (en) Novel compounds
GB201222433D0 (en) Novel compounds
GB201222435D0 (en) Novel compounds
GB201222393D0 (en) Novel compounds
GB201219554D0 (en) Novel compounds
GB201219472D0 (en) Novel compounds
GB201217387D0 (en) Novel compounds
GB201216548D0 (en) Novel compounds
GB201216551D0 (en) Novel compounds
GB201213023D0 (en) Novel compounds
GB201211246D0 (en) Novel compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: EISAI R&D MANAGEMENT CO. LTD

Free format text: FORMER OWNER: EISAI LIMITED

AT Applications terminated before publication under section 16(1)